Bayer HealthCare licenses Genomatix for microarray analysis

Genomatix announced today that Bayer HealthCare licensed Genomatix microarray analysis platform ChipInspector. ChipInspector enables biologists and bio-informaticians to analyze chip raw data from Affymetrix GeneChip and Exon Arrays. It employs a proprietary single probe approach based on latest genomic annotation from Genomatix ElDorado annotation pipeline. Starting with ChipInspector the Genomatix Microarray Analysis Pipeline integrates literature and pathway mining as well as promoter analysis on sequence level in one coherent system.

"After several successful pilot studies we are now very pleased that Bayer HealthCare licensed ChipInspector. We expect that ChipInspector will enhance the Affymetrix analysis pipeline starting from GeneChip and Exon Arrays at Bayer" states Dr. Martin Seifert, VP Microarray business and collaborative research.


Contact: Klaus May
Genomatix Software GmbH

Page: 1

Related biology news :

1. TB Alliance and Bayer launch historic global drug trials for tuberculosis
2. Bayer donates equipment to Childrens Hospital, Oakland for infectious disease research
3. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.
4. Rensselaer licenses microscope technology to Thorlabs
5. Columbia University licenses next-generation DNA sequencing technology
6. Case Western Reserve University licenses methoxyamine to Tracon
7. Yale licenses potential anti-HIV agent to Oncolys BioPharma of Japan
8. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
9. Isotron licenses ORNL cancer treatment technology
10. IC-medtech licenses promising cancer therapeutic from Summa Health System
11. Genomatix expands operations in North America

Post Your Comments:

(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded ... of its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for ... fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
Breaking Biology Technology:
Cached News: